Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Health & Science
Recent news which mentions Health & Science
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
32
33
Next >
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
Tags
Business News
Health care industry
Science
From
CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
Tags
Pharmaceuticals
Companies
Health & Science
From
CNBC.com News
Falling fertility rates pose major challenges for the global economy, report finds
March 22, 2024
Tags
Economy
World Economy
Health care industry
From
CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
March 21, 2024
Tags
Health & Science
Pharmaceuticals
Companies
From
CNBC.com News
Neuralink shares video of patient playing chess using signals from brain implant
March 20, 2024
Tags
Enterprise
Internet
Breaking News: Technology
From
CNBC.com News
FDA says safety issues with China-made syringes are 'more widespread' than previously known
March 20, 2024
Tags
Health care industry
US: News
CNBC Investigations
From
CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags
Microsoft Corp
Health & Science
Zealand Pharma A/S
From
CNBC.com News
Nvidia and Johnson & Johnson to develop new AI applications for surgery
March 18, 2024
Tags
Breaking News: Business
Hospitals
Health & Science
From
CNBC.com News
UnitedHealth Group has paid more than $2 billion to providers following cyberattack
March 18, 2024
Tags
UnitedHealth Group Inc
Internet
Enterprise
From
CNBC.com News
Doctors are turning medical generative AI into a booming business
March 16, 2024
Tags
Health care industry
Breaking News: Technology
AI / Artificial Intelligence
From
CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Business
CVS Health Corp
Weight management
From
CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
Tags
Madrigal Pharmaceuticals Inc
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
Tags
WW International Inc
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
Investing
U/S/ Markets
Health & Science
From
CNBC.com News
Biden administration investigating Change Healthcare cyberattack as disruptions continue
March 13, 2024
Tags
UnitedHealth Group Inc
Internet
Enterprise
From
CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
March 13, 2024
Tags
Biotech and Pharmaceuticals
Healthy Returns
Johnson & Johnson
From
CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Business News
From
CNBC.com News
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
March 10, 2024
Tags
Health care industry
Breaking news
Business News
From
CNBC.com News
Signos uses a glucose monitor patch and AI to help you eat healthier. Here's what it's like
March 09, 2024
Tags
Lifestyle
Internet
Breaking News: Business
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Business News
Health care industry
Business
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Eisai Co Ltd
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
UnitedHealth working to restore Change Healthcare systems by mid-March, company says
March 07, 2024
Tags
Health care industry
Breaking News: Technology
Technology
From
CNBC.com News
Oura to sell its smart rings on Amazon as Apple, Samsung wearables competition grows
March 07, 2024
Tags
e/commerce
Retail
Health
From
CNBC.com News
Cigna launches effort to cap employer insurance plan spending on weight loss drugs
March 07, 2024
Tags
US: News
Biotechnology
Eli Lilly and Co
From
CNBC.com News
Salesforce announces new AI tools for doctors
March 07, 2024
Tags
Salesforce Inc
Health care industry
Breaking News: Technology
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Biotech and Pharmaceuticals
Markets
Novo Nordisk A/S
From
CNBC.com News
Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20
March 06, 2024
Tags
Business
Health & Science
Pharmaceuticals
From
CNBC.com News
Healthy Returns: What to know about CDC’s new Covid recommendations
March 06, 2024
Tags
Health care industry
Biotech and Pharmaceuticals
Social issues
From
CNBC.com News
Dexcom announces its first ever over-the-counter CGM Stelo has been cleared by the FDA
March 05, 2024
Tags
Breaking News: Technology
Health care industry
Hospitals
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Biotech and Pharmaceuticals
Science
Novo Nordisk A/S
From
CNBC.com News
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.